VIRBAC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 347 EUR | -0.57% |
|
-2.80% | -3.48% |
| 17/04 | VIRBAC : A healthy start to 2024; outlook re-iterated |  |
| 17/04 | Virbac: sales up by almost 10% in Q1 | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | -0.57% | -2.80% | -3.48% | +12.12% | +119.07% | 3.11B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VIRP Stock
- Charts Virbac
- Comparison Chart
